Abbott To Provide Devices To NIH’s BRAIN Initiative

Abbott has agreed to provide directional deep brain stimulation, spinal cord stimulation, and dorsal root ganglion therapy devices to help NIH study treatments for chronic pain and progressive movement disorders like Parkinson's disease.

BETHESDA, MD / USA - JUNE 30, 2018: The National Institutes of Health is the nation’s medical research agency and the largest biomedical research agency in the world. - Image
• Source: shutterstock.com

Abbott Laboratories Inc. is partnering with the National Institutes of Health's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) initiative to improve therapies for a range of conditions including pain and Parkinson's.

Under the agreement, announced on 14 May, Abbott will provide directional deep brain stimulation, spinal cord stimulation and dorsal root...

More from Clinical Trials

More from R&D